1. Home
  2. INSM vs TXT Comparison

INSM vs TXT Comparison

Compare INSM & TXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSM
  • TXT
  • Stock Information
  • Founded
  • INSM 1988
  • TXT 1923
  • Country
  • INSM United States
  • TXT United States
  • Employees
  • INSM N/A
  • TXT N/A
  • Industry
  • INSM Biotechnology: Pharmaceutical Preparations
  • TXT Aerospace
  • Sector
  • INSM Health Care
  • TXT Industrials
  • Exchange
  • INSM Nasdaq
  • TXT Nasdaq
  • Market Cap
  • INSM 14.3B
  • TXT 13.6B
  • IPO Year
  • INSM 2000
  • TXT N/A
  • Fundamental
  • Price
  • INSM $81.06
  • TXT $72.32
  • Analyst Decision
  • INSM Strong Buy
  • TXT Buy
  • Analyst Count
  • INSM 15
  • TXT 10
  • Target Price
  • INSM $92.00
  • TXT $93.70
  • AVG Volume (30 Days)
  • INSM 1.8M
  • TXT 1.3M
  • Earning Date
  • INSM 02-20-2025
  • TXT 01-22-2025
  • Dividend Yield
  • INSM N/A
  • TXT 0.11%
  • EPS Growth
  • INSM N/A
  • TXT N/A
  • EPS
  • INSM N/A
  • TXT 4.33
  • Revenue
  • INSM $363,707,000.00
  • TXT $13,702,000,000.00
  • Revenue This Year
  • INSM $20.03
  • TXT $8.04
  • Revenue Next Year
  • INSM $41.61
  • TXT $4.94
  • P/E Ratio
  • INSM N/A
  • TXT $16.67
  • Revenue Growth
  • INSM 19.17
  • TXT 0.14
  • 52 Week Low
  • INSM $21.92
  • TXT $71.67
  • 52 Week High
  • INSM $84.87
  • TXT $97.34
  • Technical
  • Relative Strength Index (RSI)
  • INSM 58.18
  • TXT 32.48
  • Support Level
  • INSM $79.50
  • TXT $72.62
  • Resistance Level
  • INSM $80.28
  • TXT $72.88
  • Average True Range (ATR)
  • INSM 2.98
  • TXT 1.15
  • MACD
  • INSM 0.06
  • TXT -0.14
  • Stochastic Oscillator
  • INSM 63.38
  • TXT 14.98

About INSM Insmed Incorporated

Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.

About TXT Textron Inc.

Textron is a conglomerate that designs, manufactures, and services a range of specialty aircraft including small jets, propeller-driven airplanes, helicopters, and tilt-rotor aircraft. Textron Aviation manufactures and services Cessna and Beechcraft planes. Bell is a helicopter and tilt-rotor manufacturer and servicer for both commercial and military customers. Textron Systems produces uncrewed aircraft and armored vehicles for the military market as well as aircraft simulators and training for the commercial and military markets. Textron Industrial contains the Kautex business, which manufactures plastic fuel tanks for conventional and hybrid motor vehicles, and other subsidiaries that produce specialized vehicles such as golf carts and all-terrain vehicles.

Share on Social Networks: